Table II.
Specific mutated genes in male and female patients with cholangiocarcinoma.
| Gene | Sex | Mutant number | Male/female ratio, % | P-value |
|---|---|---|---|---|
| ERBB2 | Female | 5 | 23.81 | 0.006331 |
| AXIN2 | Female | 2 | 9.52 | 0.140075 |
| CREBBP | Female | 2 | 9.52 | 0.140075 |
| ERBB3 | Female | 2 | 9.52 | 0.140075 |
| MTOR | Female | 2 | 9.52 | 0.140075 |
| MYB | Female | 2 | 9.52 | 0.140075 |
| CCND1 | Male | 4 | 8.89 | 0.293039 |
| FBXW7 | Male | 4 | 8.89 | 0.293039 |
| FGF19 | Male | 4 | 8.89 | 0.293039 |
| FGF3 | Male | 4 | 8.89 | 0.293039 |
| FGF4 | Male | 4 | 8.89 | 0.293039 |
| PIK3CA | Male | 4 | 8.89 | 0.293039 |
| NF1 | Male | 3 | 6.67 | 0.286891 |
| STK11 | Male | 3 | 6.67 | 0.286891 |